Синдром Кушинга и беременность
Краткое описание
Методическое пособие посвящено актуальной и недостаточно известной практическим врачам теме — синдрому Кушинга, или состоянию гиперкортицизма, у женщин репродуктивного возраста. Актуальность темы определяют наблюдающийся рост частоты указанной патологии, появление новых возможностей ее своевременного диагноза и выбора тактики ведения таких пациенток как вне, так и во время беременности. В работе обсуждены клинические особенности гиперкортицизма, возможности диагностики разных причин этого состояния, риски беременности для матери и плода и тактика ведения пациенток с гиперкортицизмом. Пособие рассчитано на врачей акушеров-гинекологов, терапевтов и других специалистов, оказывающих помощь женщинам репродуктивного возраста, включая период беременности.
Главы
-
Содержание
-
Сокращения
-
Синдром Кушинга и беременность
-
Список литературы
Скачивания
Данные скачивания пока недоступны.
Библиографические ссылки
1. Ross N.S. Epidemiology of Cushing’s syndrome and subclinical disease. Endocrinol Metab Clin North Am. 1994;23:539-545.
2. Orth D.N. Cushing’s syndrome. N Engl J Med. 1995;332:791- 803.
3. Nieman L.K., Biller B.M.K., Finding J.W., et al. The diagnosis of Cushing’s syndrome: en endocrine society clinical practice guideline. J Clin Endocr Metabol. 2008;93:1526-1540.
4. Biller B.M., Grossman A.B., Stewart P.M., et al. Treatment of ACTH-dependent Cushing’s syndrome: a consensus statement. J Clin Endocr Metabol. 2008;93:2454-2462.
5. Мельниченко Г.А., Дедов И.И., Белая Ж.Е., Рожинская Л.Я., и др. Болезнь Иценко – Кушинга: клиника, диагностика, методы лечения: Федеральные клинические рекомендации. РАЭ. М., 2014.
6. Lindholm J., Juul S., Jorgensen J.O., et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab. 2001;86(1):117-123.
7. Carpenter P.C. Diagnostic evaluation of Cushing’s syndrome.
Endocrinol Metab Clin North Am. 1988;17:445-451.
8. Etxabe J., Vazquez J.A. Morbidity and mortality in Cushing disease. Clin Endocrinol. 1994;40(4):479-484.
9. Nieman L.K. Epidemiology and manifestations of Cushing’s syndrome. UpToDate. 2016.
10. Lado-Abeal J., Rodriguez-Amao J., Newell-Price J.D., et al. Menstrual abnormalities in women with Cushing’s disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab. 1998;83:3083-3086.
11. Nassi R., Ladu C., Vezzosi Ch., Manelli M. Cushing’s syndrome in pregnancy. Gynecol Endocrinol. 2015;31:102-104.
12. Tauchmanova L., Pivonello R., Di Somma C., et al. Bone demineralization and vertebral fractures in endogenous cortisol excess. J Clin Endocrinol Metab. 2006;91(15):1779-1784.
13. Graversen D., Vestergaard P., Stochholm K., et al. Mortality in Cushing’s syndrome: a systematic review and meta-analysis. Eur J Intern Med. 2012;23(3):278-282.
14. Dekkers O.M., Horvath-Puho E., Jorgensen J.O., et al. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab. 2013;98(6):2277-2284.
15. Ross E.L., Linch D.C. Cushing’s syndrome-killing disease.
Lancet. 1982;(2):646-648.
16. Dal Bo Zanon R., Fornasiero L., Boscaro M., et al. Increased factor VIII associated activities in Cushing’s syndrome. Thromb Haemost. 1982;47:116-117.
17. Boscaro M., Sonino N., Scarda A., et al. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing’s syndrome. J Clin Endocrinol Metab. 2002;87(8):3662-3666.
18. LaBrocca A., Terzolo M., Pia A., et al. Recurrent thromboembolism as a hallmark of Cushing’s syndrome. J Endocrin Invest. 1997;20:211-214.
19. Soffer L.J., Iannaccone A., Gabrilove J.L. Cushing’s syndrome: a study of fifty patients. Am J Med. 1961;30:129-132.
20. Tiemensma J., Kokshoom N.E., Biermasz N.R., et al. Subtle cognitive impairments in patients with long-term cure Cushing’s disease. J Clin Endocrinol Metab. 2010;95(6):2699-2714.
21. Bourdeau I., Bard C., Noel B., et al. Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab. 2002;87(5):1949-1954.
22. Nieman L.K. Establishing the diagnosis of Cushing’s syndrome. UpToDate. 2016.
23. Arnaldi G., Angeli A., Atkinson A.B., et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593-5602.
24. Lindsay J.R., Jonklaas J., Oldfield E.H., Nieman L.K. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab. 2005;90(5):3077-3083.
25. Nolten W.E., Lindheimer M.D., Rueckert P.A., et al. Placental CRH may be a stimulator of maternal pituitary adrenocorticotropic hormones secretion in humans. J Clin Endocrinol Metab. 1980;51(2):466-472.
26. Magiakou M.A., Mastorakos G., Rabin D., et al. The maternal hypothalamic – pituitary – adrenal axis in the third trimester of human pregnancy. Clin Endocrinol. 1996;44(4):419-428.
27. Buescher M.A., McClamrock H.D., Adashi E.Y. Cushing’s syndrome in pregnancy. Obstet Gynecol. 1992;(79):130-134.
28. Costenaro F., Rodrigues T.C., de Lima P.B., et al. A successful case of Cushing’s disease pregnancy treated with ketoconazole. Gynecol Endocrinol. 2015;31:176-178.
29. Aron D.C., Schnall A.M., Sheeler L.R. Cushing’s syndrome and pregnancy. Am J Obstet Gynecol. 1990;162:244-249.
30. Buescher M.A. Cushing’s syndrome in pregnancy.
Endocrinologist. 1996;6:357-362.
31. Lindsay J.R., Nieman L.K. The hypothalamic-pituitary-adrenal axis in pregnancy. Endocrin Rev. 2005;26:755-799.
32. Hana V., Dokoupilova M., Marek J., et al. Recurrent ACTH- independent Cushing’s syndrome in multiple pregnancies and its treatment with metyrapone. Clin Endocrinol. 2001;54:277-281.
33. Wallace C., Toth E.L., Lewanczuk R.Z., et al. Pregnancy- induced Cushing’s syndrome in multiple pregnancies. J Clin Endocrinol Metab. 1996;81:15-21.
34. Hadden D.R. Adrenal disorders of pregnancy. Endocrinol Metab Clin North Am. 1995;24:139-145.
35. Sheeler L.R. Cushing’s syndrome and pregnancy. Endocrinol Metab Clin North Am. 1994;23:619-627.
36. Bevan J.S., Gough M.H., Gillmer M.D., Burke C.W. Cushing’s syndrome in pregnancy: the timing of definitive treatment. Clin Endocrinol. 1987;27(2):225-233.
37. Pricolo V.E., Monchik J.M., Prinz R.A., et al. Management of Cushing’s syndrome secondary to adenoma during pregnancy. Surgery. 1990;108(6):1072-1077.
38. Bronstein M.D., Paraiba D.B., Jallad R.S. Management of pituitary tumors in pregnancy. Endocrinol. 2011;7(5):301-310.
39. Blanco C., Maqueda E., Rubio J.A., Rodriguez A. Cushing’s syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. J Endocrinol Invest. 2006;29:164-167.
40. Gormley M.J., Hadden D.R., Kennedy T.L., et al. Cushing’s syndrome in pregnancy – treatment with metyrapone. Clin Endocrinol. 1982;16:283-293.
41. Close C.F., Mann M.C., Watts J.F., et al. ACTH-independent Cushing’s syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol. 1993;39:753-379.
42. Connell J.M., Cordiner J., Davies D.L., et al. Pregnancy complicated by Cushing’s syndrome potential hazard of metyrapone therapy. Brit J Obst Gynecol. 1985;92(11):1192-1195.
43. Boronat M., Marrero D., Lopez-Plasencia Y., et al. Successful outcome of pregnancy in a patient with Cushing’s disease under treatment with ketoconazole. Gynecol Endocrinol. 2011;27:675-677.
44. Berwaerts J., Verhelst J., Mahler C., Abs R. Cushing’s syndrome in pregnancy treated by ketoconazole. Gynecol Endocrinol. 1999;13:175-182.
45. Amaral V.C.I., Nunes Jr.G.P. Prednisone reduces ketoconazole- induced skeletal defects in rat fetuses. Arch Toxicol. 2009;83:863-871.
2. Orth D.N. Cushing’s syndrome. N Engl J Med. 1995;332:791- 803.
3. Nieman L.K., Biller B.M.K., Finding J.W., et al. The diagnosis of Cushing’s syndrome: en endocrine society clinical practice guideline. J Clin Endocr Metabol. 2008;93:1526-1540.
4. Biller B.M., Grossman A.B., Stewart P.M., et al. Treatment of ACTH-dependent Cushing’s syndrome: a consensus statement. J Clin Endocr Metabol. 2008;93:2454-2462.
5. Мельниченко Г.А., Дедов И.И., Белая Ж.Е., Рожинская Л.Я., и др. Болезнь Иценко – Кушинга: клиника, диагностика, методы лечения: Федеральные клинические рекомендации. РАЭ. М., 2014.
6. Lindholm J., Juul S., Jorgensen J.O., et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab. 2001;86(1):117-123.
7. Carpenter P.C. Diagnostic evaluation of Cushing’s syndrome.
Endocrinol Metab Clin North Am. 1988;17:445-451.
8. Etxabe J., Vazquez J.A. Morbidity and mortality in Cushing disease. Clin Endocrinol. 1994;40(4):479-484.
9. Nieman L.K. Epidemiology and manifestations of Cushing’s syndrome. UpToDate. 2016.
10. Lado-Abeal J., Rodriguez-Amao J., Newell-Price J.D., et al. Menstrual abnormalities in women with Cushing’s disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab. 1998;83:3083-3086.
11. Nassi R., Ladu C., Vezzosi Ch., Manelli M. Cushing’s syndrome in pregnancy. Gynecol Endocrinol. 2015;31:102-104.
12. Tauchmanova L., Pivonello R., Di Somma C., et al. Bone demineralization and vertebral fractures in endogenous cortisol excess. J Clin Endocrinol Metab. 2006;91(15):1779-1784.
13. Graversen D., Vestergaard P., Stochholm K., et al. Mortality in Cushing’s syndrome: a systematic review and meta-analysis. Eur J Intern Med. 2012;23(3):278-282.
14. Dekkers O.M., Horvath-Puho E., Jorgensen J.O., et al. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab. 2013;98(6):2277-2284.
15. Ross E.L., Linch D.C. Cushing’s syndrome-killing disease.
Lancet. 1982;(2):646-648.
16. Dal Bo Zanon R., Fornasiero L., Boscaro M., et al. Increased factor VIII associated activities in Cushing’s syndrome. Thromb Haemost. 1982;47:116-117.
17. Boscaro M., Sonino N., Scarda A., et al. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing’s syndrome. J Clin Endocrinol Metab. 2002;87(8):3662-3666.
18. LaBrocca A., Terzolo M., Pia A., et al. Recurrent thromboembolism as a hallmark of Cushing’s syndrome. J Endocrin Invest. 1997;20:211-214.
19. Soffer L.J., Iannaccone A., Gabrilove J.L. Cushing’s syndrome: a study of fifty patients. Am J Med. 1961;30:129-132.
20. Tiemensma J., Kokshoom N.E., Biermasz N.R., et al. Subtle cognitive impairments in patients with long-term cure Cushing’s disease. J Clin Endocrinol Metab. 2010;95(6):2699-2714.
21. Bourdeau I., Bard C., Noel B., et al. Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab. 2002;87(5):1949-1954.
22. Nieman L.K. Establishing the diagnosis of Cushing’s syndrome. UpToDate. 2016.
23. Arnaldi G., Angeli A., Atkinson A.B., et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593-5602.
24. Lindsay J.R., Jonklaas J., Oldfield E.H., Nieman L.K. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab. 2005;90(5):3077-3083.
25. Nolten W.E., Lindheimer M.D., Rueckert P.A., et al. Placental CRH may be a stimulator of maternal pituitary adrenocorticotropic hormones secretion in humans. J Clin Endocrinol Metab. 1980;51(2):466-472.
26. Magiakou M.A., Mastorakos G., Rabin D., et al. The maternal hypothalamic – pituitary – adrenal axis in the third trimester of human pregnancy. Clin Endocrinol. 1996;44(4):419-428.
27. Buescher M.A., McClamrock H.D., Adashi E.Y. Cushing’s syndrome in pregnancy. Obstet Gynecol. 1992;(79):130-134.
28. Costenaro F., Rodrigues T.C., de Lima P.B., et al. A successful case of Cushing’s disease pregnancy treated with ketoconazole. Gynecol Endocrinol. 2015;31:176-178.
29. Aron D.C., Schnall A.M., Sheeler L.R. Cushing’s syndrome and pregnancy. Am J Obstet Gynecol. 1990;162:244-249.
30. Buescher M.A. Cushing’s syndrome in pregnancy.
Endocrinologist. 1996;6:357-362.
31. Lindsay J.R., Nieman L.K. The hypothalamic-pituitary-adrenal axis in pregnancy. Endocrin Rev. 2005;26:755-799.
32. Hana V., Dokoupilova M., Marek J., et al. Recurrent ACTH- independent Cushing’s syndrome in multiple pregnancies and its treatment with metyrapone. Clin Endocrinol. 2001;54:277-281.
33. Wallace C., Toth E.L., Lewanczuk R.Z., et al. Pregnancy- induced Cushing’s syndrome in multiple pregnancies. J Clin Endocrinol Metab. 1996;81:15-21.
34. Hadden D.R. Adrenal disorders of pregnancy. Endocrinol Metab Clin North Am. 1995;24:139-145.
35. Sheeler L.R. Cushing’s syndrome and pregnancy. Endocrinol Metab Clin North Am. 1994;23:619-627.
36. Bevan J.S., Gough M.H., Gillmer M.D., Burke C.W. Cushing’s syndrome in pregnancy: the timing of definitive treatment. Clin Endocrinol. 1987;27(2):225-233.
37. Pricolo V.E., Monchik J.M., Prinz R.A., et al. Management of Cushing’s syndrome secondary to adenoma during pregnancy. Surgery. 1990;108(6):1072-1077.
38. Bronstein M.D., Paraiba D.B., Jallad R.S. Management of pituitary tumors in pregnancy. Endocrinol. 2011;7(5):301-310.
39. Blanco C., Maqueda E., Rubio J.A., Rodriguez A. Cushing’s syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. J Endocrinol Invest. 2006;29:164-167.
40. Gormley M.J., Hadden D.R., Kennedy T.L., et al. Cushing’s syndrome in pregnancy – treatment with metyrapone. Clin Endocrinol. 1982;16:283-293.
41. Close C.F., Mann M.C., Watts J.F., et al. ACTH-independent Cushing’s syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol. 1993;39:753-379.
42. Connell J.M., Cordiner J., Davies D.L., et al. Pregnancy complicated by Cushing’s syndrome potential hazard of metyrapone therapy. Brit J Obst Gynecol. 1985;92(11):1192-1195.
43. Boronat M., Marrero D., Lopez-Plasencia Y., et al. Successful outcome of pregnancy in a patient with Cushing’s disease under treatment with ketoconazole. Gynecol Endocrinol. 2011;27:675-677.
44. Berwaerts J., Verhelst J., Mahler C., Abs R. Cushing’s syndrome in pregnancy treated by ketoconazole. Gynecol Endocrinol. 1999;13:175-182.
45. Amaral V.C.I., Nunes Jr.G.P. Prednisone reduces ketoconazole- induced skeletal defects in rat fetuses. Arch Toxicol. 2009;83:863-871.
Поступление
22 Август 2017
Категории
Copyright (c) 2017 ООО "ЭКО-Вектор"
Детали об этой монографии
Co-publisher's ISBN-13 (24)
978-5-906648-36-5
Date of first publication (11)
07.04.2017
